{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T05:59:19Z","timestamp":1784354359330,"version":"3.55.0"},"reference-count":95,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T00:00:00Z","timestamp":1701216000000},"content-version":"am","delay-in-days":363,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.jaad.2020.04.150","type":"journal-article","created":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T16:10:49Z","timestamp":1588608649000},"page":"1361-1369","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["The history of lupus throughout the ages"],"prefix":"10.1016","volume":"87","author":[{"given":"Renaud","family":"Felten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Lipsker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Sibilia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Chasset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Arnaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2020.04.150_bib1","unstructured":"Religieux de la Congr\u00e9gation de Saint-Maur. Histoire Litt\u00e9raire De La France, Vol. 6: O\u00f9 L'On Traite De L'Origine Et Du Progr\u00e8s, De La D\u00e9cadence Et Du R\u00e9tablissement Des Sciences Parmi Les Gaulois Et Parmi Les Fran\u00e7ois. Paris."},{"key":"10.1016\/j.jaad.2020.04.150_bib2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF01929020","article-title":"Historische Notizen \u00fcber Lupus","volume":"32","author":"Virchow","year":"1865","journal-title":"Arch Pathol Anat Physiol Klin Med"},{"key":"10.1016\/j.jaad.2020.04.150_bib3","series-title":"Feldbuch der Wundartzney newlich getruckt, und gebessert","author":"von Gersdorff","year":"1528"},{"key":"10.1016\/j.jaad.2020.04.150_bib4","series-title":"In two parts. With a short appendix","article-title":"De Morbis Cutaneis: a Treatise of Diseases Incident to the Skin","author":"Turner","year":"1723"},{"key":"10.1016\/j.jaad.2020.04.150_bib5","series-title":"On Cutaneous Diseases","author":"Willan","year":"1808"},{"key":"10.1016\/j.jaad.2020.04.150_bib6","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0049-0172(99)80014-6","article-title":"Pierre Cazenave and the first detailed modern description of lupus erythematosus","volume":"28","author":"Wallace","year":"1999","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jaad.2020.04.150_bib7","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.clindermatol.2003.12.015","article-title":"Early history and iconography of lupus erythematosus","volume":"22","author":"Fatovic-Ferencic","year":"2004","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jaad.2020.04.150_bib8","series-title":"Portraits of Diseases of the Skin","author":"Wilson","year":"1855"},{"key":"10.1016\/j.jaad.2020.04.150_bib9","series-title":"Trait\u00e9 th\u00e9orique et pratique des maladies de la peau","author":"Rayer","year":"1835"},{"key":"10.1016\/j.jaad.2020.04.150_bib10","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1177\/096120339700600202","article-title":"Some historical aspects of skin disease in lupus erythematosus","volume":"6","author":"Rowell","year":"1997","journal-title":"Lupus"},{"key":"10.1016\/j.jaad.2020.04.150_bib11","doi-asserted-by":"crossref","first-page":"588","DOI":"10.4103\/0019-5154.193661","article-title":"On the history of classification in dermatology","volume":"61","author":"Mukhopadhyay","year":"2016","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.jaad.2020.04.150_bib12","series-title":"Abr\u00e9g\u00e9 pratique des maladies de la peau","author":"Cazenave","year":"1833"},{"key":"10.1016\/j.jaad.2020.04.150_bib13","series-title":"Monographie des dermatoses, ou Pr\u00e9cis th\u00e9orique et pratique des maladies de la peau","author":"Alibert","year":"1832"},{"key":"10.1016\/j.jaad.2020.04.150_bib14","series-title":"Jahresbericht \u00fcber die Fortschritte der gesammten Medicin in allen L\u00e4ndern im Jahre 1845","first-page":"226","article-title":"Bericht \u00fcber die Leistungen in der Dermatologie","author":"von Hebra","year":"1846"},{"key":"10.1016\/j.jaad.2020.04.150_bib15","series-title":"A Manual of the Diseases of the Skin","author":"Balmanno Squire","year":"1868"},{"key":"10.1016\/j.jaad.2020.04.150_bib16","series-title":"Formes du lupus et son traitement. Gazette des H\u00f4pitaux Civils et Militaires (La Lancette Fran\u00e7aise)","author":"Cazenave","year":"1850"},{"key":"10.1016\/j.jaad.2020.04.150_bib17","unstructured":"Cazenave A, Chausit M. Conf\u00e9rence du 4 juin 1851. Annales Des Maladies de La Peau Et de La Syphilis. Paris; 297-299."},{"key":"10.1016\/j.jaad.2020.04.150_bib18","series-title":"Le\u00e7ons sur les maladies de la peau","author":"Cazenave","year":"1856"},{"key":"10.1016\/j.jaad.2020.04.150_bib19","series-title":"Le\u00e7ons th\u00e9oriques et cliniques sur la scrofule consid\u00e9r\u00e9e en elle-m\u00eame et dans ses rapports avec la syphilis, la dartre et l'arthritis","author":"Bazin","year":"1861"},{"key":"10.1016\/j.jaad.2020.04.150_bib20","first-page":"191","article-title":"History of lupus erythematosus","volume":"15","author":"Holubar","year":"2006","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"key":"10.1016\/j.jaad.2020.04.150_bib21","series-title":"Dubois' Lupus Erythematosus and Related Syndromes","first-page":"1","article-title":"History of Lupus","author":"Benedek","year":"2019"},{"key":"10.1016\/j.jaad.2020.04.150_bib22","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0190-9622(81)80261-7","article-title":"Distinctive cutaneous subsets in the spectrum of lupus erythematosus","volume":"4","author":"Gilliam","year":"1981","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.04.150_bib23","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/BF01921090","article-title":"Neue Beitr\u00e4ge zur Kenntnis des Lupus erythematosus","volume":"4","author":"Kaposi","year":"1872","journal-title":"Arch Derm Syphilol"},{"key":"10.1016\/j.jaad.2020.04.150_bib24","series-title":"Du lupus\/le\u00e7ons de M. le Dr \u00c9. Vidal, r\u00e9dig\u00e9es par M. Colson","author":"Vidal","year":"1879"},{"key":"10.1016\/j.jaad.2020.04.150_bib25","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1136\/bmj.1.1009.650","article-title":"On lupus & its treatment","volume":"1","author":"Hutchinson","year":"1880","journal-title":"BMJ"},{"key":"10.1016\/j.jaad.2020.04.150_bib26","first-page":"34","article-title":"The cutaneous signs of lupus erythematosus","volume":"6","author":"Gilliam","year":"1977","journal-title":"Cont Educ Fam Phys"},{"key":"10.1016\/j.jaad.2020.04.150_bib27","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1001\/archderm.1979.04010120007006","article-title":"Subacute cutaneous lupus erythematosus: a cutaneous marker for a distinct lupus\u00a0erythematosus subset","volume":"115","author":"Sontheimer","year":"1979","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2020.04.150_bib28","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/bmj.1.1412.113","article-title":"Harveian lectures on lupus","volume":"1","author":"Hutchinson","year":"1888","journal-title":"BMJ"},{"key":"10.1016\/j.jaad.2020.04.150_bib29","series-title":"Diseases of the Skin: their Description, Pathology, Diagnosis, And Treatment","author":"Radcliffe-Crocker","year":"1888"},{"key":"10.1016\/j.jaad.2020.04.150_bib30","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/00000441-189512000-00001","article-title":"On the visceral complications of erythema exudativum multiforme","volume":"110","author":"Osler","year":"1895","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.jaad.2020.04.150_bib31","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/archderm.1937.01480040046004","article-title":"Conception of lupus erythematosus and its morphologic variants","volume":"36","author":"Keil","year":"1937","journal-title":"Arch Derm Syphilol"},{"key":"10.1016\/j.jaad.2020.04.150_bib32","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2133.1902.tb16412.x","article-title":"Lupus erythematosus: a clinical study of seventy-one cases","volume":"14","author":"Sequeira","year":"1902","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2020.04.150_bib33","series-title":"Handbach der Hautkrakheiten","first-page":"298","article-title":"Lupus erythematodes","author":"Jadassohn","year":"1904"},{"key":"10.1016\/j.jaad.2020.04.150_bib34","first-page":"159","article-title":"Demonstrationen: lupus erythematodes tumidus","volume":"16","author":"Hoffmann","year":"1909","journal-title":"Derm Zeitschr"},{"key":"10.1016\/j.jaad.2020.04.150_bib35","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/archinte.1924.00110300044002","article-title":"A hitherto undescribed form of valvular and mural endocarditis","volume":"33","author":"Libman","year":"1924","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaad.2020.04.150_bib36","first-page":"765","article-title":"Relationship between lupus erythematosus and tuberculosis: critical review based on observations at necropsy","volume":"28","author":"Keil","year":"1933","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2020.04.150_bib37","first-page":"139","article-title":"Diffuse disease of the peripheral circulation usually associated with lupus erythematosus and endocarditis","volume":"50","author":"Baehr","year":"1935","journal-title":"Trans Assoc Am Phys"},{"key":"10.1016\/j.jaad.2020.04.150_bib38","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1161\/01.CIR.8.6.829","article-title":"Studies on the control of hypertension by hyphex. II. Toxic reactions and side effects","volume":"8","author":"Morrow","year":"1953","journal-title":"Circulation"},{"key":"10.1016\/j.jaad.2020.04.150_bib39","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1056\/NEJM196212272672608","article-title":"Procainamide-induced lupus erythematosus","volume":"267","author":"Ladd","year":"1962","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2020.04.150_bib40","first-page":"410","article-title":"Disseminated (systemic) lupus erythematosus","volume":"27","author":"Brunsting","year":"1952","journal-title":"Proc Staff Meet Mayo Clin"},{"key":"10.1016\/j.jaad.2020.04.150_bib41","doi-asserted-by":"crossref","first-page":"559","DOI":"10.7326\/0003-4819-37-3-559","article-title":"Systemic lupus erythematosus preceded by false-positive serologic tests for syphilis: presentation of five cases","volume":"37","author":"Haserick","year":"1952","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaad.2020.04.150_bib42","first-page":"25","article-title":"Presentation of two bone marrow elements; the tart cell and the L.E. cell","volume":"23","author":"Hargraves","year":"1948","journal-title":"Proc Staff Meet Mayo Clin"},{"key":"10.1016\/j.jaad.2020.04.150_bib43","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/00000441-195006000-00010","article-title":"Blood factor in acute disseminated lupus erythematosus; determination of gamma globulin as specific plasma fraction","volume":"219","author":"Haserick","year":"1950","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.jaad.2020.04.150_bib44","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0140-6736(63)91019-5","article-title":"Transplacental passage of antinculear antibody","volume":"1","author":"Beck","year":"1963","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2020.04.150_bib45","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1136\/bmj.1.6173.1235","article-title":"Congenital heart block and maternal systemic lupus erythematosus","volume":"1","author":"Esscher","year":"1979","journal-title":"BMJ"},{"key":"10.1016\/j.jaad.2020.04.150_bib46","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1001\/archderm.1963.01590200064012","article-title":"Lupus erythematosus and erythema multiforme-like lesions. A syndrome with characteristic immunological abnormalities","volume":"88","author":"Rowell","year":"1963","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2020.04.150_bib47","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1365-2133.1908.tb16551.x","article-title":"The relationship of lupus erythematosus and erythema multiforme, with an illustrative case","volume":"20","author":"Galloway","year":"1908","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2020.04.150_bib48","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/jid.1963.140","article-title":"The application of the fluorescent antibody technic to the investigation of lupus erythematosus and various dermatoses","volume":"41","author":"Burnham","year":"1963","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2020.04.150_bib49","doi-asserted-by":"crossref","first-page":"464","DOI":"10.4049\/jimmunol.96.3.464","article-title":"Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus","volume":"96","author":"Tan","year":"1966","journal-title":"J Immunol"},{"key":"10.1016\/j.jaad.2020.04.150_bib50","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.4049\/jimmunol.107.5.1281","article-title":"Characterization of a soluble nuclear ribonucleoprotein antigen reactive with SLE sera","volume":"107","author":"Mattioli","year":"1971","journal-title":"J Immunol"},{"key":"10.1016\/j.jaad.2020.04.150_bib51","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jbspin.2018.09.004","article-title":"Advances in the treatment of systemic lupus erythematosus: from back to the future, to the future and beyond","volume":"86","author":"Felten","year":"2019","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jaad.2020.04.150_bib52","series-title":"A Practical Synopsis of Cutaneous Diseases: According to the Arrangement of Dr. Willan, Exhibiting a Concise View of the Diagnostic Symptoms and the Method of Treatment","author":"Bateman","year":"1818"},{"key":"10.1016\/j.jaad.2020.04.150_bib53","series-title":"Journal of Cutaneous Diseases Including Syphilis","year":"1835"},{"key":"10.1016\/j.jaad.2020.04.150_bib54","series-title":"\u00c9l\u00e9mens de pathologie m\u00e9dicale","author":"Requin","year":"1843"},{"key":"10.1016\/j.jaad.2020.04.150_bib55","series-title":"Elements of General Radio-therapy for Practitioners","author":"Freund","year":"1904"},{"key":"10.1016\/j.jaad.2020.04.150_bib56","series-title":"X-rays and Radium in the Treatment of Diseases of the Skin","author":"MacKee","year":"1921"},{"key":"10.1016\/j.jaad.2020.04.150_bib57","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1039\/c2pp25120e","article-title":"History of phototherapy in dermatology","volume":"12","author":"Honigsmann","year":"2013","journal-title":"Photochem Photobiol Sci"},{"key":"10.1016\/j.jaad.2020.04.150_bib59","first-page":"223","article-title":"A postgraduate lecture on lupus erythematosus","volume":"4","author":"Payne","year":"1894","journal-title":"Clin J"},{"key":"10.1016\/j.jaad.2020.04.150_bib60","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0140-6736(51)91643-1","article-title":"Treatment of lupus erythematosus with mepacrine","volume":"2","author":"Page","year":"1951","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2020.04.150_bib61","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1001\/archderm.1955.01540280096023","article-title":"Introduction of quinacrine in treatment of lupus erythematosus","volume":"71","author":"Zakon","year":"1955","journal-title":"AMA Arch Derm"},{"key":"10.1016\/j.jaad.2020.04.150_bib62","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1001\/archderm.1956.01550060046009","article-title":"Plaquenil in the treatment of discoid lupus erythematosus; a preliminary report","volume":"73","author":"Lewis","year":"1956","journal-title":"AMA Arch Derm"},{"key":"10.1016\/j.jaad.2020.04.150_bib63","doi-asserted-by":"crossref","first-page":"e000303","DOI":"10.1136\/lupus-2018-000303","article-title":"10 most important contemporary challenges in the management of SLE","volume":"6","author":"Felten","year":"2019","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.jaad.2020.04.150_bib64","first-page":"827","article-title":"Rheumatoid arthritis and its treatment by gold salts: the results of six years' experience","volume":"20","author":"Forestier","year":"1935","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.jaad.2020.04.150_bib65","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1001\/jama.1936.02770410025006","article-title":"Lupus erythematosus: a modification of therapy with gold compounds","volume":"107","author":"Alden","year":"1936","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2020.04.150_bib66","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-2133.1986.tb05720.x","article-title":"Treatment of chronic discoid lupus erythematosus with an oral gold compound (auranofin)","volume":"115","author":"Dalziel","year":"1986","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2020.04.150_bib67","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0025-6196(24)00526-3","article-title":"The effect of a hormone of the\u00a0adrenal\u00a0cortex (17-hydroxy-11-dehydrocorticosterone; compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis","volume":"24","author":"Hench","year":"1949","journal-title":"Proc Staff Meet Mayo Clin"},{"key":"10.1016\/j.jaad.2020.04.150_bib68","author":"Felten"},{"key":"10.1016\/j.jaad.2020.04.150_bib69","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1001\/jama.1947.02890170001001","article-title":"Nitrogen mustard therapy in cutaneous blastomatous disease","volume":"135","author":"Osborne","year":"1947","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2020.04.150_bib70","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1001\/archinte.1954.00240290025003","article-title":"Nitrogen mustard in treatment of systemic lupus erythematosus","volume":"93","author":"Dubois","year":"1954","journal-title":"AMA Arch Intern Med"},{"key":"10.1016\/j.jaad.2020.04.150_bib71","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1056\/NEJM198603063141004","article-title":"Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs","volume":"314","author":"Austin","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2020.04.150_bib72","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/0140-6736(92)92292-N","article-title":"Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis","volume":"340","author":"Boumpas","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2020.04.150_bib73","first-page":"141","article-title":"Treatment of systemic lupus erythematosus with antimetabolites. Relations between the clinical course and immunological reactions","volume":"47","author":"Cruchaud","year":"1967","journal-title":"Helv Med Acta Suppl"},{"key":"10.1016\/j.jaad.2020.04.150_bib74","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/art.1780140511","article-title":"Azathioprine in the treatment of systemic lupus erythematosus. A controlled study","volume":"14","author":"Sztejnbok","year":"1971","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2020.04.150_bib75","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1056\/NEJM200010193431604","article-title":"Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group","volume":"343","author":"Chan","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2020.04.150_bib76","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1681\/ASN.2004080686","article-title":"Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis","volume":"16","author":"Chan","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jaad.2020.04.150_bib77","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa043731","article-title":"Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis","volume":"353","author":"Ginzler","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2020.04.150_bib78","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1681\/ASN.2008101028","article-title":"Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis","volume":"20","author":"Appel","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jaad.2020.04.150_bib79","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1055\/s-2001-17109","article-title":"\u201cCatastrophic systemic lupus erythematosus\u201d with Rosai-Dorfman sinus histiocytosis. Successful treatment with anti-CD20\/rutuximab","volume":"126","author":"Petschner","year":"2001","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.jaad.2020.04.150_bib80","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1046\/j.1365-2141.2002.03278.x","article-title":"Anti-CD20 monoclonal antibody (Rituximab) for life-threatening autoimmune haemolytic anaemia in a patient with systemic lupus erythematosus","volume":"116","author":"Perrotta","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaad.2020.04.150_bib81","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/art.34359","article-title":"Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study","volume":"64","author":"Rovin","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2020.04.150_bib82","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/art.27233","article-title":"Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II\/III systemic lupus erythematosus evaluation of rituximab trial","volume":"62","author":"Merrill","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2020.04.150_bib83","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1177\/0961203309106174","article-title":"Rituximab in systemic lupus erythematosus: a systematic review of off-label use in 188 cases","volume":"18","author":"Ramos-Casals","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.jaad.2020.04.150_bib84","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/ndt\/gfs285","article-title":"Beyond the LUNAR trial. Efficacy of rituximab in refractory lupus nephritis","volume":"28","author":"Weidenbusch","year":"2013","journal-title":"Nephrol Dial Transpl"},{"key":"10.1016\/j.jaad.2020.04.150_bib85","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.autrev.2011.10.009","article-title":"Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: pooled data from European cohorts","volume":"11","author":"Diaz-Lagares","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaad.2020.04.150_bib86","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1002\/art.27541","article-title":"Safety and efficacy of rituximab in systemic lupus erythematosus: results from 136 patients from the French AutoImmunity and Rituximab registry","volume":"62","author":"Terrier","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2020.04.150_bib87","doi-asserted-by":"crossref","first-page":"6","DOI":"10.4049\/jimmunol.166.1.6","article-title":"Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus","volume":"166","author":"Zhang","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.jaad.2020.04.150_bib88","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0140-6736(10)61354-2","article-title":"Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial","volume":"377","author":"Navarra","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2020.04.150_bib89","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1002\/art.30613","article-title":"A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus","volume":"63","author":"Furie","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2020.04.150_bib90","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.autrev.2017.11.009","article-title":"Targeting interferons and their pathways in systemic lupus erythematosus","volume":"17","author":"Chasset","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaad.2020.04.150_bib91","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.2147\/DDDT.S170969","article-title":"Spotlight on anifrolumab and its potential for the treatment of moderate-to-severe systemic lupus erythematosus: evidence to date","volume":"13","author":"Felten","year":"2019","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.jaad.2020.04.150_bib92","doi-asserted-by":"crossref","first-page":"e208","DOI":"10.1016\/S2665-9913(19)30076-1","article-title":"Type I interferon inhibitor anifrolumab in active systemic lupus erythematosus (TULIP-1): a randomised, controlled, phase 3 trial","volume":"1","author":"Furie","year":"2019","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.jaad.2020.04.150_bib93","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1912196","article-title":"Trial of anifrolumab in active systemic lupus erythematosus","volume":"382","author":"Morand","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2020.04.150_bib94","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0140-6736(18)31363-1","article-title":"Baricitinib for systemic\u00a0lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"392","author":"Wallace","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2020.04.150_bib95","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/S0140-6736(18)32167-6","article-title":"Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients\u00a0with active systemic lupus erythematosus: results of a multicentre, double-blind, phase 2, randomised, controlled study","volume":"392","author":"van Vollenhoven","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2020.04.150_bib96","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/annrheumdis-2019-215396","article-title":"Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial","volume":"79","author":"He","year":"2020","journal-title":"Ann Rheum Dis"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962220307726?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962220307726?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T23:06:47Z","timestamp":1759273607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962220307726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":95,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S0190962220307726"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2020.04.150","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The history of lupus throughout the ages","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2020.04.150","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}